News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
652,666 Results
Type
Article (52544)
Company Profile (214)
Press Release (599908)
Section
Business (183871)
Career Advice (2712)
Deals (33769)
Drug Delivery (105)
Drug Development (78977)
Employer Resources (166)
FDA (16495)
Job Trends (15558)
News (322411)
Policy (32784)
Tag
Academia (2848)
Alliances (47085)
Alzheimer's disease (1282)
Approvals (16405)
Artificial intelligence (146)
Bankruptcy (338)
Best Places to Work (11828)
Biotechnology (145)
Breast cancer (128)
Cancer (1143)
Cardiovascular disease (107)
Career advice (2284)
Cell therapy (255)
Clinical research (62917)
Collaboration (412)
Compensation (94)
COVID-19 (2779)
C-suite (103)
Data (1130)
Diabetes (160)
Diagnostics (6382)
Drug pricing (94)
Earnings (67981)
Employer resources (148)
Events (99566)
Executive appointments (317)
FDA (17046)
Funding (356)
Gene therapy (194)
GLP-1 (666)
Government (4679)
Healthcare (19432)
Infectious disease (2872)
Inflammatory bowel disease (112)
Interviews (506)
IPO (14942)
Job creations (4088)
Job search strategy (1918)
Layoffs (472)
Legal (7475)
Lung cancer (184)
Manufacturing (187)
Medical device (13535)
Medtech (13540)
Mergers & acquisitions (18885)
Metabolic disorders (446)
Neuroscience (1579)
NextGen Class of 2024 (6956)
Non-profit (4897)
Northern California (1438)
Obesity (258)
Opinion (222)
Patents (98)
People (54509)
Phase I (19480)
Phase II (27472)
Phase III (21124)
Pipeline (464)
Postmarket research (2566)
Preclinical (7609)
Radiopharmaceuticals (235)
Rare diseases (237)
Real estate (5776)
Regulatory (22003)
Research institute (2513)
Resumes & cover letters (413)
Southern California (1303)
Startups (3621)
United States (12838)
Vaccines (643)
Weight loss (205)
Date
Today (46)
Last 7 days (672)
Last 30 days (3606)
Last 365 days (34863)
2024 (31916)
2023 (39265)
2022 (50189)
2021 (54919)
2020 (54219)
2019 (48021)
2018 (36746)
2017 (32938)
2016 (32503)
2015 (37108)
2014 (28743)
2013 (23745)
2012 (25519)
2011 (26205)
2010 (23386)
Location
Africa (940)
Arizona (144)
Asia (38450)
Australia (6572)
California (3287)
Canada (1166)
China (244)
Colorado (154)
Connecticut (152)
Europe (88347)
Florida (427)
Georgia (114)
Illinois (342)
Indiana (203)
Maryland (553)
Massachusetts (2346)
Michigan (160)
Minnesota (255)
New Jersey (876)
New York (913)
North Carolina (726)
Northern California (1438)
Ohio (132)
Pennsylvania (758)
South America (1297)
Southern California (1303)
Texas (422)
Utah (96)
Washington State (348)
652,666 Results for "helsinn healthcare sa".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Helsinn Group announces AKYNZEO® (fosnetupitant/palonosetron) injection is now available in a ready-to-use vial in the US
Helsinn Group (“Helsinn”), a global pharmaceutical company with a track record of over forty-five years of commercial execution and a strong focus in supportive care, oncology and dermato-oncology, is pleased to announce that AKYNZEO® (fosnetupitant/palonosetron) injection is now available in the US in a ready-to-use vial.
June 24, 2024
·
5 min read
Press Releases
Helsinn Group appoints Riccardo Carbucicchio to the Board of Directors
September 20, 2024
·
2 min read
Press Releases
Acquisition of Ovizio Imaging Systems SA
October 17, 2024
·
1 min read
RELIEF THERAPEUTICS Holding SA Announces Results of Annual General Meeting
RELIEF THERAPEUTICS Holding SA announces the results of its annual general meeting (AGM) of shareholders, which took place in Geneva today.
June 27, 2024
·
3 min read
Helsinn closes financing agreement with BancaStato to support business objectives and growth
Helsinn Group announces the signing of a new financing agreement with BancaStato, effective from September 2023.
October 10, 2023
·
3 min read
Helsinn announces publication of data evaluating impact of AKYNZEO® (fosnetupitant/palonosetron) on treatment outcomes and healthcare costs
Helsinn Group (“Helsinn”), a fully integrated global biopharma company with a track record of over forty years of commercial execution and a strong focus in oncology and rare diseases, announces the publication of real-world evidence of AKYNZEO® (fosnetupitant with palonosetron) injection/for injection in the journal Advances in Therapy.
June 12, 2023
·
8 min read
Deals
Stryker completes acquisition of SERF SAS
Stryker (NYSE: SYK), a leading global medical technology company, announced today that it has completed the previously announced acquisition of SERF SAS, a France -based joint replacement company, from Menix.
March 21, 2024
·
4 min read
RELIEF THERAPEUTICS Holding SA Announces Results of Extraordinary General Meeting
RELIEF THERAPEUTICS Holding SA announces the results of the extraordinary general meeting of shareholders, which took place in Geneva , Friday, April 26, 2024.
April 26, 2024
·
4 min read
Press Releases
ChemoMetec makes offer to buy Ovizio Imaging Systems SA
September 23, 2024
·
1 min read
Business
ExcellGene SA and Cytovance Biologics Join Forces to Transform Large Molecule Biologics Development and Manufacture
ExcellGene SA proudly announces its strategic collaboration with Cytovance Biologics, a renowned Contract Development and Manufacturing Organization based in the USA.
May 8, 2024
·
3 min read
1 of 65,267
Next
